Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 3.002% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CC1CN(C(=S)Nc2ccc(F)cc2F)CC(C)O1
b. O=C(N/N=C/c1cc(Br)cs1)C(O)c1ccccc1
c. O=C(COC(=O)c1sc2ccccc2c1Cl)NC1CCCCC1
d. COc1cccc(-c2ccc(NC(=O)C3CCCN(Cc4ccco4)C3)cc2)c1
Answer: b. O=C(N/N=C/c1cc(Br)cs1)C(O)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(N/N=C/c1cc(Br)cs1)C(O)c1ccccc1
O=C(N/N=C/c1cc(Br)cs1)C(O)c1ccccc1
N-[(E)-(4-bromothiophen-2-yl)methylideneamino]-2-hydroxy-2-phenylacetamide